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Gold	   nanoparticles	   (AuNPs)	   have	   attracted	   a	   great	   deal	   of	   attention	   in	   recent	   years	   because	   of	   their	  
enhanced	   and	   tunable	   optical	   properties,	   easy	   production	   and	   functionalization	   as	   well	   as	   their	   good	  
biocompatibility	   (Shukla	   et	   al,	   2005).	   Moreover,	   gold	   nanoparticles	   set	   themselves	   apart	   from	   other	  
nanoplatforms	   thanks	   to	   the	   unique	   localized	   surface	   plasmon	   resonance	   which	   can	   be	   used	   in	   the	  
multimodal	  treatment	  of	  cancer,	  an	  example	  of	  which	  is	  photothermal	  therapy	  (Huang	  et	  al,	  2008).	  AuNPs	  
are	  then	  front-­‐runners	  for	  use	  as	  targeting	  moieties	  in	  external	  physical	  trigger	  based	  cancer	  treatment.	  
The	   aim	  of	   this	   study	   is	   to	   investigate	   cancer	   targeted	  AuNPs	   in	   their	   role	   as	   nanosonosensitizers	  which	  
increase	   the	  acoustic	   cavitation	  effect,	   typically	  associated	  with	   sonodynamic	   therapy,	  a	  developing	  non-­‐
invasive	  anticancer	  approach	  where	  ultrasound	  (US)	  is	  used	  to	  trigger	  sonosensitizer	  cytotoxicity	  leading	  to	  
cancer	  cell	  death	  (Tachibana	  et	  al,	  2008).	  	  
In	  this	  work,	  AuNPs	  have	  been	  produced	  via	  the	  reduction	  of	  tetrachlorauric	  acid	  with	  sodium	  citrate	  and	  
decorated	  with	  2	   kDa	  mPEG-­‐SH,	   to	  provide	   stealth	   features,	   and	  3.5	   kDa	   folate-­‐PEG-­‐SH	   (FA-­‐PEG-­‐AuNPs),	  
which	   acts	   as	   a	   targeting	   agent	   for	   the	   biorecognition	   of	   folate	   receptor	   expressing	   cancer	   cells.	   AuNPs	  
have	   been	   characterized	   by	   TEM,	   UV-­‐Vis	   and	   photon	   correlation	   spectroscopy	   in	   order	   to	   assess	   size,	  
morphology	  and	  colloidal	  stability.	  In	  vitro	  experiments	  were	  performed	  on	  human	  cell	  lines	  that	  express	  a	  
folate	   receptor,	   i.e.	   epidermoid	   carcinoma	   KB	   and	   colon	   carcinoma	   HCT116,	   and	   that	   do	   not	   express	   a	  
folate	  receptor,	  i.e.	  breast	  cancer	  MCF-­‐7.	  Cell	  association	  has	  been	  investigated	  using	  confocal	  microscopy	  
and	   atomic	   absorption	   spectrometry.	   FA-­‐PEG-­‐AuNP's	   ability	   to	   selectively	   kill	   cancer	   cells	   under	  US	   field	  
exposure	  has	  been	  studied	  at	  1.8	  MHz	  and	  two	  different	  energy	  densities	  inside	  the	  cell	  tube;	  8x10-­‐6	  J	  cm-­‐2	  
for	  5	  minutes	  at	  30°C	  and	  8x10-­‐5	  J	  cm-­‐2	  for	  5	  minutes	  at	  45°C.	  The	  treatment's	  effect	  on	  cell	  growth	  has	  been	  
investigated	   using	   a	  WST-­‐1	   proliferation	   assay,	   cell	   death	   and	   reactive	   oxygen	   species	   (ROS)	   production	  
studied	  using	  flow	  cytometric	  analysis	  (FCA).	  Experiments	  have	  also	  been	  carried	  out	  with	  the	  free	  radical	  
scavenger	  N-­‐acetylcysteine	  (NAC)	  to	  assess	  the	  role	  of	  ROS	  in	  cancer	  cell	  death.	  
FA-­‐PEG-­‐AuNPs	   possess	   a	   hydrodynamic	   size	   of	   about	   30	   nm	   and	   selectively	   target	   folate	   receptor	  
expressing	  cancer	  cells,	  KB	  and	  HCT-­‐116,	  and	  do	  not	  associate	  with	  MCF-­‐7	  cells	  that	  do	  not	  express	  folate	  
receptors.	  A	  60%	  reduction	  in	  cancer	  cell	  growth	  was	  only	  observed	  in	  folate	  receptor	  expressing	  cells,	  KB	  
and	  HCT116,	  upon	  incubation	  with	  FA-­‐PEG-­‐AuNPs	  and	  US	  treatment,	  as	  compared	  to	  control	  conditions,	  72	  
hours	   from	   sonodynamic	   treatment,	   confirming	   our	   hypothesis	   that	   gold	   nanoparticles	   can	   act	   as	  
nanosonosensitizers.	   	  Moreover,	  FCA	  only	  showed	  a	  significant	   increase	   in	   late	  apoptotic/necrotic	  cells	   in	  
KB	   and	   HCT116	   cells	   that	   had	   been	   treated	   with	   FA-­‐PEG-­‐AuNPs	   and	   US	   at	   the	   two	   different	   energy	  
densities.	  A	   specific	  ROS	  production	  pattern	  was	  also	  observed	  after	  FA-­‐PEG-­‐AuNPs	  and	  US	   treatment	  at	  
the	   two	   different	   energy	   densities.	   Interestingly,	   NAC	   only	   suppresses	   cyototoxicity	   and	   ROS	   production	  
when	  used	  with	  the	   lower	  energy	  density	  sonodynamic	  treatment,	  while	   it	  seems	  to	  play	  a	  minor	  role	   in	  
suppressing	   these	   effects	   at	   the	   higher	   energy	   density,	   which	   displayed	   a	   moderate	   hyperthermic	  
condition.	   In	  conclusion,	  the	  simultaneous	  exploitation	  of	  the	  targeting	  capacity	  of	  the	  gold	  nanoparticles	  
and	   the	   sensitizing	   effect	   afforded	   by	   a	   localized	   external	   stimulus,	   namely	   ultrasound,	   make	   them	  
promising	   candidates	   for	   the	   site-­‐specific	   treatment	   of	   cancer.	   Furthermore,	   this	   in	   vitro	   study	   can	   be	  
considered	  a	  proof	  of	  concept	  for	  AuNP	  use	  as	  nanosonosensitizers	   in	  the	  ultrasound	  based	  treatment	  of	  
cancer.	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